Answers are grounded in this paper and cite their sources.
A feature of the recent history of medicine has been the introduction of treatments whose costs are orders of magnitude higher than doctors are used to justifying. Having previously been left almost untouched by these developments, psychiatrists are beginning to find themselves in the position previously occupied by renal physicians, transplant surgeons, and oncologists – having to face uncomfortable decisions about costs versus benefits and the rationing of medical care. To a considerable extent this is a consequence of the launch of the new, ‘atypical’, and ‘superior’ neuroleptic, clozapine.
No takes yet. Share an insight, caveat, or question.
McKenna et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: